TRIPS Waiver Arguments
AMI Respond to some of the arguments made against the TRIPS Waiver with eight reseons why the Intellectual property waiver for COVID-19 Vaccines will work
On 5th May, 2021, the USA under President Joe Biden joined a global, progressive movement at the World Trade Organisation (WTO) to suspend certain Intellectual Property (IP) protections for COVID-19 vaccines.
“These extraordinary times and circumstances call for extraordinary measures,” the US Trade Representative Ambassador, Katherine Tai, said. “The US supports the waiver of IP protections on COVID-19 vaccines to help end the pandemic.”
Ireland and EU countries, however, have not followed suit while there has been a predictable push-back by spokespeople for the pharmaceutical industry.
